LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming October 13, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. ("Aardvark†or the "Companyâ€) (NASDAQ: AARD) securities between February 10, 2025 and May 14, 2026 inclusive (the "Class Periodâ€). IF YOU SUFFERED A LOSS ON YOUR AARDVARK THERAPEUTICS, INC. INVESTMENTS, CLICK HERE TO INQUIRE A. ...